Public Employees Retirement Association of Colorado’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$489K Hold
8,961
﹤0.01% 1035
2026
Q1
$426K Hold
8,961
﹤0.01% 1048
2025
Q4
$470K Hold
8,961
﹤0.01% 1010
2025
Q3
$581K Hold
8,961
﹤0.01% 903
2025
Q2
$436K Hold
8,961
﹤0.01% 1037
2025
Q1
$305K Hold
8,961
﹤0.01% 1204
2024
Q4
$353K Hold
8,961
﹤0.01% 1176
2024
Q3
$421K Hold
8,961
﹤0.01% 1082
2024
Q2
$484K Sell
8,961
-117
-1% -$6.77K ﹤0.01% 966
2024
Q1
$619K Sell
9,078
-2,556
-22% -$183K ﹤0.01% 882
2023
Q4
$728K Sell
11,634
-357
-3% -$19.7K ﹤0.01% 816
2023
Q3
$544K Sell
11,991
-381
-3% -$19.7K ﹤0.01% 911
2023
Q2
$695K Hold
12,372
﹤0.01% 850
2023
Q1
$560K Sell
12,372
-5,835
-32% -$283K ﹤0.01% 956
2022
Q4
$740K Hold
18,207
﹤0.01% 829
2022
Q3
$1.19M Buy
18,207
+11,290
+163% +$818K 0.01% 647
2022
Q2
$420K Hold
6,917
﹤0.01% 1122
2022
Q1
$434K Hold
6,917
﹤0.01% 1224
2021
Q4
$524K Hold
6,917
﹤0.01% 1196
2021
Q3
$774K Hold
6,917
﹤0.01% 912
2021
Q2
$1.12M Hold
6,917
﹤0.01% 758
2021
Q1
$843K Hold
6,917
﹤0.01% 861
2020
Q4
$1.06M Hold
6,917
0.01% 724
2020
Q3
$579K Hold
6,917
﹤0.01% 896
2020
Q2
$508K Buy
+6,917
New +$404K ﹤0.01% 961

Other funds holding CRSP

Public Employees Retirement Association of Colorado's CRSP Position: Q2 2026 in Review

Public Employees Retirement Association of Colorado held its CRISPR Therapeutics (CRSP) position steady in Q2 2026 at 8,961 shares worth $489K. The position accounts for ﹤0.01% of the portfolio, ranked #1035.

Public Employees Retirement Association of Colorado first reported a position in CRSP in Q2 2020 and has held it in 25 quarters since. The position peaked at $1.19M in Q3 2022. 521 funds tracked by Wall St. Rank hold CRSP as of Q2 2026.

  • Public Employees Retirement Association of Colorado held 8,961 shares of CRISPR Therapeutics worth $489K as of Q2 2026.
  • Public Employees Retirement Association of Colorado left its CRISPR Therapeutics share count unchanged in Q2 2026.
  • CRISPR Therapeutics made up ﹤0.01% of Public Employees Retirement Association of Colorado's portfolio in Q2 2026, its #1035 holding.
  • Public Employees Retirement Association of Colorado first reported a position in CRISPR Therapeutics in Q2 2020 and has held it in 25 quarters since.
  • Public Employees Retirement Association of Colorado's CRISPR Therapeutics position peaked at $1.19M in Q3 2022.
  • 521 funds tracked by Wall St. Rank held CRISPR Therapeutics as of Q2 2026.

Based on Public Employees Retirement Association of Colorado's 13F filing for Q2 2026, filed 11 Aug 2026.